Zentist has raised $11.0M in total across 2 funding rounds.
Zentist's investors include Costanoa Ventures, All Iron Ventures, Andreessen Horowitz, Audrey Capital, BoxGroup, Brainchild, Encomenda Smart Capital, SciFi VC, Seven Seven Six, Slow Ventures, The General Partnership, Aaron Levie.
Zentist is a San Francisco-based technology company founded in 2015 that builds Remit AI, a cloud-based platform automating dental revenue cycle management (RCM) for dental service organizations (DSOs), dental groups, and practices across the U.S.[1][2][5] It tackles the $2.1 billion annual revenue loss in the dental industry from inefficient legacy billing systems by using robotic process automation (RPA), AI, and machine learning to handle insurance claims, payments, denials, and analytics, serving hundreds of DSOs and thousands of practices to boost collections, cut costs, and scale operations.[1][2][3][5] The company has raised $19.8M, achieved strong growth with metrics like 64% month-over-month revenue increase in pitch materials, and recently earned SOC 2 Type II certification while launching Cavi AR for AR and claims management.[1][2]
Zentist emerged in 2015 (with some sources noting 2016) to bring financial transparency and automation to dental billing, addressing error-prone manual processes in a consolidating industry.[1][3] Co-founded by CEO Dipesh Patel and a Chief Business Officer, the team leveraged AI and RPA expertise to create Remit AI, starting with core insurance billing automation like claim validation, posting, and appeals.[1][2][3] Early traction built through serving emerging DSOs facing scaling pressures, evolving into a full RCM suite with add-ons like educational bootcamps and executive dashboards, trusted by leaders at firms like Oakpoint, GLDP, and The Smilist Management.[3][5]
Zentist rides the dental industry consolidation wave, where DSOs manage thousands of practices amid rising insurance complexity and $2.1B leakage from outdated systems—perfect timing as AI automates healthcare admin post-pandemic.[1][2][3] Market forces like scaling pressures and 200M Americans facing dental access issues favor its B2B model, influencing the ecosystem by enabling DSOs to focus on care over billing, much like how AI tools transformed general healthcare RCM.[2][4][5] Its growth validates fintech-healthtech convergence, de-risking investments in underserved verticals.
Zentist is poised to dominate dental RCM as DSOs consolidate further, with expansions like Cavi AR signaling a full-stack platform play amid AI healthcare booms. Trends like advanced analytics and subscription scaling will drive $100M+ revenue potential, evolving its influence from billing fixer to DSO growth engine—cementing its role in taming the $2.1B chaos that sparked its founding.[1][2][4][5]
Zentist has raised $11.0M across 2 funding rounds. Most recently, it raised $8.0M Series A in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2019 | $8.0M Series A | Costanoa Ventures | |
| Mar 1, 2017 | $3.0M Seed | All Iron Ventures, Andreessen Horowitz, Audrey Capital, BoxGroup, Brainchild, Encomenda Smart Capital, SciFi VC, Seven Seven Six, Slow Ventures, The General Partnership, Aaron Levie, Emil Michael, Josh Elman, Loic Le Meur, Manish Patel, Ryan Sarver, Steve Martocci |
